Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Aleve® Speaks The Painful Truth, Encouraging Consumers to Explore Their Pain Management Options
From Bayer
Via Business Wire
News headline image
Bayer and Thermo Fisher Scientific Collaborate to Increase Patient Access to Precision Cancer Medicines
From Bayer
Via Business Wire
News headline image
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth
From Bayer
Via Business Wire
News headline image
Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant
From Bayer
Via Business Wire
News headline image
Bayer Wins Third Consecutive Trial Victory
From Bayer
Via Business Wire
News headline image
Bayer Receives U.S. FDA Breakthrough Therapy Designation for BAY 2927088 for Non-Small Cell Lung Cancer Harboring HER2 Activating Mutations
From Bayer
Via Business Wire
News headline image
Bayer initiates Phase II study with first-in-class anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis
From Bayer
Via Business Wire
News headline image
First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure
From Bayer
Via Business Wire
News headline image
Bayer Unveils Groundbreaking Solar Energy Projects at Sites in New Jersey and California
From Bayer
Via Business Wire
News headline image
Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
From Bayer
Via Business Wire
News headline image
MiraLAX® Exposes The Gut Gap™, Proving Women are More Stressed and More Constipated than Men
From Bayer
Via Business Wire
News headline image
Bayer Reveals Latest Prostate Cancer Data at 2024 ASCO GU Cancers Symposium
From Bayer
Via Business Wire
News headline image
Bayer starts Phase II study NIRVANA to evaluate elinzanetant in women with sleep disturbances associated with menopause
From Bayer
Via Business Wire
News headline image
Bayer’s elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies
From Bayer
Via Business Wire
News headline image
Bayer Statement on Win in Jones Roundup™ Trial
From Bayer
Via Business Wire
News headline image
Bayer and Salus Optima Partner on AI-Enabled Healthy Aging Journey
From Bayer
Via Business Wire
News headline image
Bayer Earns Top Score in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index for Sixth Consecutive Year
From Bayer
Via Business Wire
News headline image
Bayer and CrossBay Medical to develop novel Intrauterine System Inserter
From Bayer
Via Business Wire
News headline image
Bayer and Hurdle launch precision health strategic partnership
From Bayer
Via Business Wire
News headline image
Bayer Announces Publication of Health Economic Model Evaluation at RSNA, Providing New Insights Into Cost Effectiveness and Capacity Needs of Supplemental Screening Modalities for Dense Breasts
From Bayer
Via Business Wire
News headline image
Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation
From Bayer
Via Business Wire
News headline image
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination
From Bayer
Via Business Wire
News headline image
Bayer Provides Update on Aliqopa® (copanlisib)
From Bayer
Via Business Wire
News headline image
New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment
From Bayer
Via Business Wire
News headline image
Bayer and Recursion focus research collaboration on Oncology
From Bayer
Via Business Wire
News headline image
Alka-Seltzer® Teams Up with George Kittle to Encourage Football Fans to ‘Say Yes’ to Going Big on Game Days
From Bayer
Via Business Wire
News headline image
New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
From Bayer
Via Business Wire
News headline image
New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
From Bayer
Via Business Wire
News headline image
Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies
From Bayer
Via Business Wire
News headline image
FieldView and Combyne Platform Integration Helps Farmers Better Manage Grain Marketing and Build Profitability Insights
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.